Palbociclib and Letrozole in Advanced Breast CancerRichard S. Finn, Dennis J. Slamon, Miguel Martín et al.|New England Journal of Medicine|2016Cited by 2.9k
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)Fátima Cardoso, Eric P. Winer, Alexandru Eniu et al.|Annals of Oncology|2016Cited by 2.1k
The clonal and mutational evolution spectrum of primary triple-negative breast cancersSohrab P. Shah, J Costello, Andrew Roth et al.|Nature|2012Cited by 2k
2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trialIan Smith, Martine Piccart, Marion Procter et al.|The Lancet|2007Cited by 1.5k
5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)Fátima Cardoso, Eric P. Winer, Shani Paluch–Shimon et al.|Annals of Oncology|2020Cited by 1.4k